Download FREE Report Sample
Download Free sampleGlucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
GLP Analogs Market contains market size and forecasts of GLP Analogs in global, including the following market information:
Global GLP Analogs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global GLP Analogs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five GLP Analogs companies in 2021 (%)
The global GLP Analogs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Exenatied Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of GLP Analogs include Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb and Amylin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the GLP Analogs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GLP Analogs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global GLP Analogs Market Segment Percentages, by Type, 2021 (%)
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Global GLP Analogs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global GLP Analogs Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Other
Global GLP Analogs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global GLP Analogs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GLP Analogs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies GLP Analogs revenues share in global market, 2021 (%)
Key companies GLP Analogs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies GLP Analogs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
